A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin.

ABSTRACT: As COVID-19 (coronavirus disease 2019) continues to rapidly spread throughout the world, the incidence varies greatly among different countries. These differences raise the question whether nations with a lower incidence share any medical commonalities that could be used not only to explain that lower incidence but also to provide guidance for potential treatments elsewhere. Such a treatment would be particularly valuable if it could be used as a prophylactic against SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) transmission, thereby effectively slowing the spread of the disease while we await the wide availability of safe and effective vaccines. Here, we show that countries with routine mass drug administration of prophylactic chemotherapy including ivermectin have a signif

SUBMITTER: Hellwig MD 

PROVIDER: S-EPMC7698683 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature